Stockreport

Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer

Keros Therapeutics, Inc. - common stock  (KROS) 
PDF LEXINGTON, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focu [Read more]